Women’s Health Market By Treatment Type and Disease Indication - Global Industry Analysis And Forecast To 2025

Published On : November 2018 Pages : 130 Category: Pharma & Healthcare Report Code : HC111741

Women’s Health Market By Treatment Type (Hormonal Treatment (Parathyroid Hormone Therapy, Combination Therapy, Estrogen Therapy, Thyroid Replacement Therapy, Progestin Therapy and Other Hormonal Treatment) and Non-Hormonal Treatment (Antibiotics, Bisphosphonates, Targeted Therapy Drugs and Other Non-Hormonal Treatment)) and Disease Indication (Urinary Tract Infection, Osteoporosis, Cancer, Uterine Fibroid, Hypothyroidism, Contraceptive, Post-Menopausal Syndrome and Other Disease Indications) - Global Industry Analysis And Forecast To 2025

Industry Outlook

Women’s Health refers to the field of medicine that deals with treatment & diagnosis of disorders and conditions related to women’s health that affects women emotionally & physically. Women’s Health has various unique issues also some issues that are common for men & women but have different effect on women. Health issues that are unique in women are; menopause, pregnancy & conditions relate to female organs. Growth is seen in Women’s Health diagnosis & treatment due to; increasing number of cases related to women’s disorders, rising funds availability for R&D, more technical developments, rising awareness about the reliable treatments available, etc. Therefore, the Women’s Health Market is anticipated to expand and has tremendous scope during the forecast period. The global Women’s Health Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Women’s Health Market is based on segment, by Treatment Type the market is segmented into Hormonal Treatment (Parathyroid Hormone Therapy, Combination Therapy, Estrogen Therapy, Thyroid Replacement Therapy, Progestin Therapy and Other Hormonal Treatment) and Non-Hormonal Treatment (Antibiotics, Bisphosphonates, Targeted Therapy Drugs and Other Non-Hormonal Treatment), and by Disease Indication the market is segmented into Urinary Tract Infection, Osteoporosis, Cancer, Uterine Fibroid, Hypothyroidism, Contraceptive, Post-Menopausal Syndrome and Other Disease Indications.

  • Women’s Health Market, By Treatment Type
  • Hormonal Treatment
  • Parathyroid Hormone Therapy
  • Combination Therapy
  • Estrogen Therapy
  • Thyroid Replacement Therapy
  • Progestin Therapy
  • Other Hormonal Treatment
  • Non-Hormonal Treatment
  • Antibiotics
  • Bisphosphonates
  • Targeted Therapy Drugs
  • Other Non-Hormonal Treatment
  • Women’s Health Market, By Disease Indication
  • Urinary Tract Infection
  • Osteoporosis
  • Cancer
  • Uterine Fibroid
  • Hypothyroidism
  • Contraceptive
  • Post-Menopausal Syndrome
  • Other Disease Indication

Regional Insights

On a global front, the Women’s Health Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Women’s Health Market owing to; high investment for the R&D, specific treatments, increasing number of cases related to various diseases, etc.

Women’s Health Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc, Lupin Pharmaceuticals Inc., Eli Lilly and Company, Allergan Plc, Novartis AG, AstraZeneca, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novo Nordisk A/S, Bayer AG, Amgen Inc. and Sanofi. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Pfizer Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Lupin Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Allergan Plc
  • Novartis AG
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • Bayer AG
  • Amgen Inc.
  • Sanofi

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Women’s Health Market, By Treatment Type, Estimates and Forecast, 2014-2025 ($Million)

o   Hormonal Treatment

§  Parathyroid Hormone Therapy

§  Combination Therapy

§  Estrogen Therapy

§  Thyroid Replacement Therapy

§  Progestin Therapy

§  Other Hormonal Treatment

o   Non-Hormonal Treatment

§  Antibiotics

§  Bisphosphonates

§  Targeted Therapy Drugs

§  Other Non-Hormonal Treatment

o   Women’s Health Market, By Disease Indication, Estimates and Forecast, 2014-2025 ($Million)

o   Urinary Tract Infection

o   Osteoporosis

o   Cancer

o   Uterine Fibroid

o   Hypothyroidism

o   Contraceptive

o   Post-Menopausal Syndrome

o   Other Disease Indication

o   Women’s Health Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Women’s Health Market, By Country

o   U.S. Women’s Health Market

o   Canada Women’s Health Market

o   Mexico Women’s Health Market

o   Europe

§  Europe Women’s Health Market, By Country

o   Germany Women’s Health Market

o   UK Women’s Health Market

o   France Women’s Health Market

o   Russia Women’s Health Market

o   Italy Women’s Health Market

o   Rest of Europe Women’s Health Market

o   Asia-Pacific

§  Asia-Pacific Women’s Health Market, By Country

o   China Women’s Health Market

o   Japan Women’s Health Market

o   South Korea  Women’s Health Market

o   India Women’s Health Market

o   Southeast Asia Women’s Health Market

o   Rest of Asia-Pacific Women’s Health Market

o   South America

§  South America Women’s Health Market, By Country

o   Brazil Women’s Health Market

o   Argentina Women’s Health Market

o   Columbia Women’s Health Market

o   Rest of South America Women’s Health Market

o   Middle East and Africa

§  Middle East and Africa Women’s Health Market, By Country

o   Saudi Arabia Women’s Health Market

o   UAE Women’s Health Market

o   Egypt Women’s Health Market

o   Nigeria Women’s Health Market

o   South Africa Women’s Health Market

o   Rest of MEA Women’s Health Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Women’s Health  Market, By Treatment Type

5.1.     Introduction

5.2.     Global Women’s Health  Revenue and Market Share by Treatment Type (2014-2018)

5.2.1.  Global Women’s Health  Revenue and Revenue Share by Treatment Type (2014-2018)

5.3.     Hormonal Treatment

5.3.1.  Global Hormonal Treatment Revenue and Growth Rate (2014-2018)

5.3.2.  Global Hormonal Treatment By Type (2014-2018)

5.3.3.  Parathyroid Hormone Therapy

5.3.3.1.  Global Parathyroid Hormone Therapy Revenue and Growth Rate (2014-2018)

5.3.4.  Combination Therapy

5.3.4.1.  Global Combination Therapy Revenue and Growth Rate (2014-2018)

5.3.5.  Estrogen Therapy

5.3.5.1.  Global Estrogen Therapy Revenue and Growth Rate (2014-2018)

5.3.6.  Thyroid Replacement Therapy

5.3.6.1.  Global Thyroid Replacement Therapy Revenue and Growth Rate (2014-2018)

5.3.7.  Progestin Therapy

5.3.7.1.  Global Progestin Therapy Revenue and Growth Rate (2014-2018)

5.3.8.  Other Hormonal Treatment

5.3.8.1.  Global Other Hormonal Treatment Revenue and Growth Rate (2014-2018)

5.4.     Non-Hormonal Treatment

5.4.1.  Global Non-Hormonal Treatment Revenue and Growth Rate (2014-2018)

5.4.2.  Global Non-Hormonal Treatment By Type (2014-2018)

5.4.3.  Antibiotics

5.4.3.1.  Global Antibiotics Revenue and Growth Rate (2014-2018)

5.4.4.  Bisphosphonates

5.4.4.1.  Global Bisphosphonates Revenue and Growth Rate (2014-2018)

5.4.5.  Targeted Therapy Drugs

5.4.5.1.  Global Targeted Therapy Drugs Revenue and Growth Rate (2014-2018)

5.4.6.  Other Non-Hormonal Treatment

5.4.6.1.  Global Other Non-Hormonal Treatment Revenue and Growth Rate (2014-2018)

6.       Women’s Health  Market, By Disease Indication

6.1.     Introduction

6.2.     Global Women’s Health  Revenue and Market Share by Disease Indication (2014-2018)

6.2.1.  Global Women’s Health  Revenue and Revenue Share by Disease Indication (2014-2018)

6.3.     Urinary Tract Infection

6.3.1.  Global Urinary Tract Infection Revenue and Growth Rate (2014-2018)

6.4.     Osteoporosis

6.4.1.  Global Osteoporosis Revenue and Growth Rate (2014-2018)

6.5.     Cancer

6.5.1.  Global Cancer Revenue and Growth Rate (2014-2018)

6.6.     Uterine Fibroid

6.6.1.  Global Uterine Fibroid Revenue and Growth Rate (2014-2018)

6.7.     Hypothyroidism

6.7.1.  Global Hypothyroidism Revenue and Growth Rate (2014-2018)

6.8.     Contraceptive

6.8.1.  Global Contraceptive Revenue and Growth Rate (2014-2018)

6.9.     Post-Menopausal Syndrome

6.9.1.  Global Post-Menopausal Syndrome Revenue and Growth Rate (2014-2018)

6.10. Other Disease Indication

6.10.1.      Global Other Disease Indication Revenue and Growth Rate (2014-2018)

7.       Women’s Health  Market, By Region

7.1.     Introduction

7.2.     Global Women’s Health  Revenue and Market Share by Regions

7.2.1.  Global Women’s Health  Revenue by Regions (2014-2018)

7.3.     North America Women’s Health  by Countries

7.3.1.  North America Women’s Health  Revenue and Growth Rate (2014-2018)

7.3.2.  North America Women’s Health  Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Women’s Health  by Countries

7.4.1.  Europe Women’s Health  Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Women’s Health  Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Women’s Health  by Countries

7.5.1.  Asia-Pacific Women’s Health  Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Women’s Health  Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Women’s Health  by Countries

7.6.1.  South America Women’s Health  Revenue and Growth Rate (2014-2018)

7.6.2.  South America Women’s Health  Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Women’s Health  by Countries

7.7.1.  Middle East and Africa Women’s Health  Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Women’s Health  Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Women’s Health  Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     Pfizer Inc.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Johnson & Johnson

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     GlaxoSmithKline plc

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Lupin Pharmaceuticals Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Eli Lilly and Company

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Allergan Plc

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Novartis AG

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     AstraZeneca

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     F. Hoffmann-La Roche Ltd.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Merck & Co. Inc.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Novo Nordisk A/S

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

8.12. Bayer AG

8.12.1.      Business Overview

8.12.2.       Service Portfolio

8.12.3.      Strategic Developments

8.12.4.       Revenue and Market Share

8.13. Amgen Inc.

8.13.1.      Business Overview

8.13.2.       Service Portfolio

8.13.3.      Strategic Developments

8.13.4.       Revenue and Market Share

8.14. Sanofi

8.14.1.      Business Overview

8.14.2.       Service Portfolio

8.14.3.      Strategic Developments

8.14.4.       Revenue and Market Share

9.       Global Women’s Health  Market Competition, by Manufacturer

9.1.     Global Women’s Health  Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Women’s Health  Price By Region (2016-2017)

9.3.     Top 5 Women’s Health  Manufacturer Market Share

9.4.     Market Competition Trend

10.    Women’s Health  Market Forecast (2018-2025)

10.1. Global Women’s Health  Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Women’s Health  Market Forecast by Regions (2018-2025)

10.2.1.      North America Women’s Health  Market Forecast (2018-2025)

10.2.1.1. United States Women’s Health  Market Forecast (2018-2025)

10.2.1.2. Canada Women’s Health  Market Forecast (2018-2025)

10.2.1.3. Mexico Women’s Health  Market Forecast (2018-2025)

10.2.2.      Europe Women’s Health  Market Forecast (2018-2025)

10.2.2.1. Germany Women’s Health  Market Forecast (2018-2025)

10.2.2.2. France Women’s Health  Market Forecast (2018-2025)

10.2.2.3. UK Women’s Health  Market Forecast (2018-2025)

10.2.2.4. Russia Women’s Health  Market Forecast (2018-2025)

10.2.2.5. Italy Women’s Health  Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Women’s Health  Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Women’s Health  Market Forecast (2018-2025)

10.2.3.1. China Women’s Health  Market Forecast (2018-2025)

10.2.3.2. Japan Women’s Health  Market Forecast (2018-2025)

10.2.3.3. Korea Women’s Health  Market Forecast (2018-2025)

10.2.3.4. India Women’s Health  Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Women’s Health  Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Women’s Health  Market Forecast (2018-2025)

10.2.4.      South America Women’s Health  Market Forecast (2018-2025)

10.2.4.1. Brazil Women’s Health  Market Forecast (2018-2025)

10.2.4.2. Argentina Women’s Health  Market Forecast (2018-2025)

10.2.4.3. Columbia Women’s Health  Market Forecast (2018-2025)

10.2.4.4. Rest of South America Women’s Health  Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Women’s Health  Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Women’s Health  Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Women’s Health  Market Forecast (2018-2025)

10.2.5.3. Egypt Women’s Health  Market Forecast (2018-2025)

10.2.5.4. Nigeria Women’s Health  Market Forecast (2018-2025)

10.2.5.5. South Africa Women’s Health  Market Forecast (2018-2025)

10.2.5.6. Turkey Women’s Health  Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Women’s Health  Market Forecast (2018-2025)

10.3. Women’s Health  Market Forecast by Treatment Type (2018-2025)

10.3.1.      Women’s Health  Forecast by Treatment Type (2018-2025)

10.3.2.      Women’s Health  Market Share Forecast by Treatment Type (2018-2025)

10.4. Women’s Health  Market Forecast by Disease Indication (2018-2025)

10.4.1.      Women’s Health  Forecast by Disease Indication (2018-2025)

10.4.2.      Women’s Health  Market Share Forecast by Disease Indication (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Women’s Health Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Women’s Health Revenue and Revenue Share by Treatment Type (2014-2018)
Figure Global Hormonal Treatment Revenue and Growth Rate (2014-2018)
Figure Global Parathyroid Hormone Therapy Revenue and Growth Rate (2014-2018)
Figure Global Combination Therapy Revenue and Growth Rate (2014-2018)
Figure Global Estrogen Therapy Revenue and Growth Rate (2014-2018)
Figure Global Thyroid Replacement Therapy Revenue and Growth Rate (2014-2018)
Figure Global Progestin Therapy Revenue and Growth Rate (2014-2018)
Figure Global Other Hormonal Treatment Revenue and Growth Rate (2014-2018)
Figure Global Non-Hormonal Treatment Revenue and Growth Rate (2014-2018)
Figure Global Antibiotics Revenue and Growth Rate (2014-2018)
Figure Global Bisphosphonates Revenue and Growth Rate (2014-2018)
Figure Global Targeted Therapy Drugs Revenue and Growth Rate (2014-2018)
Figure Global Other Non-Hormonal Treatment Revenue and Growth Rate (2014-2018)
Table Global Women’s Health Revenue and Revenue Share by Disease Indication (2014-2018)
Figure Global Urinary Tract Infection Revenue and Growth Rate (2014-2018)
Figure Global Osteoporosis Revenue and Growth Rate (2014-2018)
Figure Global Cancer Revenue and Growth Rate (2014-2018)
Figure Global Uterine Fibroid Revenue and Growth Rate (2014-2018)
Figure Global Hypothyroidism Revenue and Growth Rate (2014-2018)
Figure Global Contraceptive Revenue and Growth Rate (2014-2018)
Figure Global Post-Menopausal Syndrome Revenue and Growth Rate (2014-2018)
Figure Global Other Disease Indication Revenue and Growth Rate (2014-2018)
Table Global Women’s Health Revenue by Regions (2014-2018)
Figure North America Women’s Health Growth Rate (2014-2018)
Figure North America Women’s Health Revenue and Growth Rate (2014-2018)
Figure North America Women’s Health by Countries (2014-2018)
Figure North America Women’s Health Revenue (Million USD) by Countries (2014-2018)
Figure United States Women’s Health Growth Rate (2014-2018)
Figure United States Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Women’s Health Growth Rate (2014-2018)
Figure Canada Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Women’s Health Growth Rate (2014-2018)
Figure Mexico Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Women’s Health Growth Rate (2014-2018)
Figure Europe Women’s Health Revenue and Growth Rate (2014-2018)
Figure Europe Women’s Health by Countries (2014-2018)
Figure Europe Women’s Health Revenue (Million USD) by Countries (2014-2018)
Figure Germany Women’s Health Growth Rate (2014-2018)
Figure Germany Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Women’s Health Growth Rate (2014-2018)
Figure France Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Women’s Health Growth Rate (2014-2018)
Figure UK Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Women’s Health Growth Rate (2014-2018)
Figure Russia Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Women’s Health Growth Rate (2014-2018)
Figure Italy Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Women’s Health Growth Rate (2014-2018)
Figure Rest of Europe Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Women’s Health Growth Rate (2014-2018)
Figure Asia-Pacific Women’s Health Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Women’s Health by Countries (2014-2018)
Figure Asia-Pacific Women’s Health Revenue (Million USD) by Countries (2014-2018)
Figure China Women’s Health Growth Rate (2014-2018)
Figure China Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Women’s Health Growth Rate (2014-2018)
Figure Japan Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Women’s Health Growth Rate (2014-2018)
Figure Korea Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Women’s Health Growth Rate (2014-2018)
Figure India Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Women’s Health Growth Rate (2014-2018)
Figure Southeast Asia Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Women’s Health Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Women’s Health Growth Rate (2014-2018)
Figure South America Women’s Health Revenue and Growth Rate (2014-2018)
Figure South America Women’s Health by Countries (2014-2018)
Figure South America Women’s Health Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Women’s Health Growth Rate (2014-2018)
Figure Brazil Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Women’s Health Growth Rate (2014-2018)
Figure Argentina Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Women’s Health Growth Rate (2014-2018)
Figure Columbia Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Women’s Health Growth Rate (2014-2018)
Figure Rest of South America Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Women’s Health Growth Rate (2014-2018)
Figure Middle East and Africa Women’s Health Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Women’s Health by Countries (2014-2018)
Figure Middle East and Africa Women’s Health Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Women’s Health Growth Rate (2014-2018)
Figure Saudi Arabia Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Women’s Health Growth Rate (2014-2018)
Figure United Arab Emirates Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Women’s Health Growth Rate (2014-2018)
Figure Egypt Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Women’s Health Growth Rate (2014-2018)
Figure Nigeria Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Women’s Health Growth Rate (2014-2018)
Figure South Africa Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Women’s Health Growth Rate (2014-2018)
Figure Turkey Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Women’s Health Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Women’s Health Revenue (Millions USD) and Growth Rate (2014-2018)
Table Pfizer Inc. Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Pharmaceuticals Inc. Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Plc Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Ltd. Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk A/S Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer AG Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Inc. Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Women’s Health Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Women’s Health Market Share by Manufacturer
Figure Global Women’s Health Revenue and Market Share by Manufacturer
Table Global Women’s Health Price by Region (2016-2017)
Figure Top 5 Women’s Health Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Women’s Health Revenue (Millions USD) and Growth Rate (2018-2025)
Table Women’s Health Market Forecast by Regions (2018-2025)
Figure North America Women’s Health Market Forecast (2018-2025)
Figure United States Women’s Health Market Forecast (2018-2025)
Figure Canada Women’s Health Market Forecast (2018-2025)
Figure Mexico Women’s Health Market Forecast (2018-2025)
Figure Europe Women’s Health Market Forecast (2018-2025)
Figure Germany Women’s Health Market Forecast (2018-2025)
Figure France Women’s Health Market Forecast (2018-2025)
Figure UK Women’s Health Market Forecast (2018-2025)
Figure Russia Women’s Health Market Forecast (2018-2025)
Figure Italy Women’s Health Market Forecast (2018-2025)
Figure Rest of Europe Women’s Health Market Forecast (2018-2025)
Figure Asia-Pacific Women’s Health Market Forecast (2018-2025)
Figure China Women’s Health Market Forecast (2018-2025)
Figure Japan Women’s Health Market Forecast (2018-2025)
Figure Korea Women’s Health Market Forecast (2018-2025)
Figure India Women’s Health Market Forecast (2018-2025)
Figure Southeast Asia Women’s Health Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Women’s Health Market Forecast (2018-2025)
Figure South America Women’s Health Market Forecast (2018-2025)
Figure Brazil Women’s Health Market Forecast (2018-2025)
Figure Argentina Women’s Health Market Forecast (2018-2025)
Figure Columbia Women’s Health Market Forecast (2018-2025)
Figure Rest of South America Women’s Health Market Forecast (2018-2025)
Figure Middle East and Africa Women’s Health Market Forecast (2018-2025)
Figure Saudi Arabia Women’s Health Market Forecast (2018-2025)
Figure United Arab Emirates Women’s Health Market Forecast (2018-2025)
Figure Egypt Women’s Health Market Forecast (2018-2025)
Figure Nigeria Women’s Health Market Forecast (2018-2025)
Figure South Africa Women’s Health Market Forecast (2018-2025)
Figure Turkey Women’s Health Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Women’s Health Market Forecast (2018-2025)
Figure Global Women’s Health Forecast by Treatment Type (2018-2025)
Figure Global Women’s Health Market Share Forecast by Treatment Type (2018-2025)
Figure Global Women’s Health Forecast by Treatment Type (2018-2025)
Figure Global Women’s Health Forecast by Disease Indication (2018-2025)
Figure Global Women’s Health Market Share Forecast by Disease Indication (2018-2025)
Figure Global Women’s Health Forecast by Disease Indication (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*